From Financial Modeling Prep: 2025-03-07 09:00:02

DarioHealth Corp. (NASDAQ:DRIO) is set to report a quarterly loss of $0.16 per share, with revenue projected at $7.39 million. Despite a negative P/E ratio of -0.85, a positive price-to-sales ratio of 1.31 shows investor confidence. Financial metrics indicate challenges in cash flow but manageable debt levels and sufficient liquidity for DarioHealth. CEO Erez Raphael and CCO Steven Nelson will lead the upcoming earnings call, offering insights into the company’s financial health and strategic direction.



Read more at Financial Modeling Prep:: DarioHealth Corp. (NASDAQ:DRIO) Earnings Preview: …